![]() | Up a level |
Martinelli, P, Pau, ECDS, Cox, T, Sainz, B, Dusetti, N, Greenhalf, W, Rinaldi, L, Costello, E, Ghaneh, P, Malats, N et al (show 6 more authors)
(2017)
GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer.
Gut, 66 (9).
pp. 1665-1676.
Rosato, V, Gomez-Rubio, P, Molina-Montes, E, Marquez, M, Lohr, M, O'Rorke, M, Michalski, CW, Molero, X, Farre, A, Perea, J et al (show 25 more authors)
(2021)
Gallbladder disease and pancreatic cancer risk: a multicentric case-control European study.
EUROPEAN JOURNAL OF CANCER PREVENTION, 30 (6).
pp. 423-430.
Molina-Montes, E, Gomez-Rubio, P, Marquez, M, Rava, M, Lohr, M, Michalski, CW, Molero, X, Farre, A, Perea, J, Greenhalf, W et al (show 26 more authors)
(2018)
Risk of pancreatic cancer associated with family history of cancer and other medical conditions by accounting for smoking among relatives.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 47 (2).
pp. 473-483.
Gomez-Rubio, P, Rosato, V, Marquez, M, Bosetti, C, Molina-Montes, E, Rava, M, Pinero, J, Michalski, CW, Farre, A, Molero, X et al (show 33 more authors)
(2017)
A systems approach identifies time-dependent associations of multimorbidities with pancreatic cancer risk.
ANNALS OF ONCOLOGY, 28 (7).
pp. 1618-1624.